ECOG-ACRIN Cancer Research Group opens clinical trial for women with newly diagnosed

[News]

In direct response to recommendations made by a National Institutes of Health scientific consensus panel, the ECOG-ACRIN Cancer Research Group announced today the opening of E4112, a clinical trial for women with newly diagnosed ductal carcinoma in situ (DCIS) of the breast who, together with their doctors, will use the results of a magnetic resonance imaging (MRI) exam to determine whether to undergo a lumpectomy or a mastectomy.

More... (http://www.news-medical.net/news/20150206/ECOG-ACRIN-Cancer-Research-Group-opens-clinical-trial-for-women-with-newly-diagnosed-DCIS.aspx)